These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 15223899

  • 1. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
    Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y.
    Transplantation; 2004 Jun 27; 77(12):1826-33. PubMed ID: 15223899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
    Kahan BD, Karlix JL, Ferguson RM, Leichtman AB, Mulgaonkar S, Gonwa TA, Skerjanec A, Schmouder RL, Chodoff L.
    Transplantation; 2003 Oct 15; 76(7):1079-84. PubMed ID: 14557756
    [Abstract] [Full Text] [Related]

  • 4. FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.
    Tedesco-Silva H, Lorber MI, Foster CE, Sollinger HW, Mendez R, Carvalho DB, Shapiro R, Rajagopalan PR, Mayer H, Slade J, Kahan BD, FTY720A2202 clinical study group.
    Clin Transplant; 2009 Oct 15; 23(5):589-99. PubMed ID: 19719728
    [Abstract] [Full Text] [Related]

  • 5. FTY720 immunomodulation: optimism for improved transplant regimens.
    Ferguson R.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):549S-553S. PubMed ID: 15041404
    [Abstract] [Full Text] [Related]

  • 6. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
    Tedesco-Silva H, Szakaly P, Shoker A, Sommerer C, Yoshimura N, Schena FP, Cremer M, Hmissi A, Mayer H, Lang P, FTY720 2218 Clinical Study Group.
    Transplantation; 2007 Oct 15; 84(7):885-92. PubMed ID: 17984842
    [Abstract] [Full Text] [Related]

  • 7. The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients.
    Westhoff TH, Schmidt S, Glander P, Liefeld L, Martini S, Offermann G, Neumayer HH, Zidek W, van der Giet M, Budde K.
    Nephrol Dial Transplant; 2007 Aug 15; 22(8):2354-8. PubMed ID: 17526535
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
    Tedesco-Silva H, Pescovitz MD, Cibrik D, Rees MA, Mulgaonkar S, Kahan BD, Gugliuzza KK, Rajagopalan PR, Esmeraldo Rde M, Lord H, Salvadori M, Slade JM, FTY720 Study Group.
    Transplantation; 2006 Dec 27; 82(12):1689-97. PubMed ID: 17198261
    [Abstract] [Full Text] [Related]

  • 9. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 10. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction.
    Kovarik JM, Schmouder RL, Barilla D, Büche M, Rouilly M, Berthier S, Wang Y, Van Saders C, Mayer T, Gottlieb AB.
    Ann Pharmacother; 2004 Apr 15; 38(7-8):1153-8. PubMed ID: 15138297
    [Abstract] [Full Text] [Related]

  • 11. FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship.
    Skerjanec A, Tedesco H, Neumayer HH, Cole E, Budde K, Hsu CH, Schmouder R.
    J Clin Pharmacol; 2005 Nov 15; 45(11):1268-78. PubMed ID: 16239360
    [Abstract] [Full Text] [Related]

  • 12. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study.
    Hoitsma AJ, Woodle ES, Abramowicz D, Proot P, Vanrenterghem Y, FTY720 Phase II Transplant Study Group.
    Nephrol Dial Transplant; 2011 Nov 15; 26(11):3802-5. PubMed ID: 21911597
    [Abstract] [Full Text] [Related]

  • 13. FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia.
    Salvadori M, Budde K, Charpentier B, Klempnauer J, Nashan B, Pallardo LM, Eris J, Schena FP, Eisenberger U, Rostaing L, Hmissi A, Aradhye S, FTY720 0124 Study Group.
    Am J Transplant; 2006 Dec 15; 6(12):2912-21. PubMed ID: 17061999
    [Abstract] [Full Text] [Related]

  • 14. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
    Sommerer C, Morath C, Giese T, Meuer S, Zeier M.
    Transplant Proc; 2008 Jun 15; 40(5):1416-8. PubMed ID: 18589120
    [Abstract] [Full Text] [Related]

  • 15. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 15; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 16. FTY720: early clinical experience.
    Dragun D, Fritsche L, Boehler T, Peters H, Budde K, Neumayer HH.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):544S-548S. PubMed ID: 15041403
    [Abstract] [Full Text] [Related]

  • 17. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.
    Suzuki T, Jin MB, Shimamura T, Yamashita K, Taniguchi M, Nomura M, Yokota R, Fukai M, Magata S, Horiuchi H, Fujita M, Nagashima K, Furukawa H, Todo S.
    Transpl Int; 2004 Nov 15; 17(10):574-84. PubMed ID: 15592714
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
    Nart A, Sipahi S, Aykas A, Uslu A, Hoşcoşkun C, Toz H.
    Transplant Proc; 2008 Nov 15; 40(1):189-92. PubMed ID: 18261583
    [Abstract] [Full Text] [Related]

  • 19. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.
    Mulgaonkar S, Tedesco H, Oppenheimer F, Walker R, Kunzendorf U, Russ G, Knoflach A, Patel Y, Ferguson R, FTYA121 study group.
    Am J Transplant; 2006 Aug 15; 6(8):1848-57. PubMed ID: 16771816
    [Abstract] [Full Text] [Related]

  • 20. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 15; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.